Xiting Jia

BCR-ABL1 transcript decline ratio combined BCR-ABL1IS as a precise predictor for imatinib response and outcome in the patients with chronic myeloid leukemia

Z. Ge, Chunhua Song, Lidong Zhao, 2020, Journal of Cancer.